Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Supernus Provides Regulatory Updates for SPN-812 and SPN-830

americanpharmaceuticalreviewNovember 20, 2020

Tag: Supernus , SPN-812 , SPN-830 , ADHD , Parkinson’s disease

PharmaSources Customer Service